Clik here to view.
Cerveau Technologies and Sinotau Pharmaceutical Group Announce Sinotau’s...
BOSTON Sinotau Pharmaceuticals has announced today an agreement with HTA CO. LTD for launching a new β-amyloid imaging agent for Alzheimer’s disease in China. “This agreement will greatly contribute...
View ArticleClik here to view.
Health Canada Approves Otsuka and Lundbeck’s Abilify Maintena® (Aripiprazole...
MONTREAL Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for ABILIFY MAINTENA (aripiprazole for prolonged release injectable...
View ArticleClik here to view.
Altemia™治疗镰状细胞病(SCD)患儿获得临床成功
佛罗里达州里维埃拉海滩 — (美国商业资讯) — Sancilio Pharmaceuticals Company, Inc. (SPCI)今天宣布，一项评估Altemia™口服软明胶胶囊治疗5-17岁镰状细胞病患儿有效性和安全性的临床研究获得阳性先期结果 (https://clinicaltrials.gov/ct2/show/NCT02973360)。...
View ArticleClik here to view.
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation in the United States in patients with...
View ArticleClik here to view.
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced detailed results from the Phase 3 REPRISE trial of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD)....
View ArticleClik here to view.
Celltrion Healthcare Presents Phase III Switching Data Supporting the...
SAN DIEGO New data presented at the 2017 American College of Rheumatology (ACR) Annual Meeting show that CT-P10 is comparable to reference rituximab in terms of efficacy, pharmacodynamics (PD) and...
View ArticleClik here to view.
武田药品工业株式会社公布2017年上半年业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO:4502)： 武田增长引擎带动基础营收增长了6.7% 基础营收增长+6.7%，各地区业务均斩获了不俗的业绩（美国+16.7%、日本 +0.3%、欧洲与加拿大 +4.2%、 新兴市场...
View ArticleClik here to view.
Alexion Receives New Japanese Patent for Soliris® (eculizumab), Extending...
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that the Japanese Patent Office (JPO) has issued patent No. 6224059, directed to the composition of matter of eculizumab...
View ArticleClik here to view.
武田在美国血液学会第59届年会上呈报的数据有望重塑血液肿瘤治疗的未来
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:...
View ArticleClik here to view.
Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502), (“Takeda”) today announced that data from an 18-month interim analysis of the ongoing Phase 2 DEN-204 trial of its live, attenuated...
View ArticleClik here to view.
アヴェオ・オンコロジーとEUSA Pharma、腎細胞がんでチボザニブとニボルマブを検討する第1/2相TiNivo試験の第1相部分の有望な結果を発表
米マサチューセッツ州ケンブリッジ & 英ヘメルヘムステッド （ビジネスワイヤ） — アヴェオ・オンコロジー（NASDAQ:AVEO）とEUSA Pharmaは本日、TiNivo試験の進行中の第1相部分から得た有望な結果を報告したと発表しました。TiNivo試験は、進行性腎細胞がん（RCC）の治療を目的として、ブリストル・マイヤーズ...
View ArticleClik here to view.
Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and Portal Instruments today announced a collaboration to develop and commercialize Portal’s needle-free drug...
View ArticleClik here to view.
EOC Pharma Completed Series B Financing From Leading Global Investors
SHANGHAI EOC Pharma Group (EOC), a leading oncology-focused development and commercialization company in China, today announced that it has completed a $32 million Series B financing led by Taikang...
View ArticleClik here to view.
Co-Diagnostics, Inc. Manufacturing Joint Venture Breaks Ground in India
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, and Synbiotics...
View ArticleClik here to view.
Sterigenics International LLC Changes Name to Sotera Health LLC
CLEVELAND Sterigenics International LLC (the “Company”) announced today that it has changed its parent company name to Sotera Health LLC. Its three operating companies – Nelson Labs™, Nordion® and...
View ArticleClik here to view.
Sonitor® and ZulaFly Partner with Life Care, Inc. to Break New Ground in...
STAMFORD, Conn. Sonitor announced today that Life Care, Inc., a long-term care network located in South Australia, has deployed their RTLS platform at Life Care’s Reynella facility. This RTLS...
View ArticleClik here to view.
Toyoda Gosei to Begin Collaboration with EBM Corporation in Developing...
KIYOSU, Japan Toyoda Gosei Co., Ltd. has concluded an agreement with EBM Corporation*1, a medical device startup company started at Waseda University in Japan, to work together for the development...
View ArticleClik here to view.
豊田合成、「e-Rubber」を用いた手術訓練シミュレータの開発・普及に向けてイービーエム社とコラボレーションを開始
愛知県清須市 （ビジネスワイヤ） – 豊田合成株式会社（本社：愛知県清須市､社長：宮﨑 直樹）は、医療機器開発を行う早稲田大学発のベンチャー企業であるイービーエム株式会社（本社：東京都大田区､社長：朴 栄光）※1との間で、「e-Rubber」※2を用いた手術訓練シミュレータの開発・普及に関する協働活動契約を締結しました。...
View ArticleClik here to view.
Chugai’s ALK Inhibitor “Alecensa®” Approved for the Treatment of First Line...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Genentech Inc., a member of the Roche Group, obtained approval from the U.S. Food and Drug Administration (FDA), for...
View ArticleClik here to view.
Strategic Minority Investment Company MiNA Therapeutics Enters Into...
TOKYO Sosei Group Corporation (‘Sosei’; TSE Mothers Index 4565), is pleased to note that our strategic minority investment company MiNA Therapeutics (‘MiNA’) has announced a collaboration and...
View Article